Literature DB >> 2044654

Identity of human Lyb-2 and CD72 and localization of the gene to chromosome 9.

I Von Hoegen1, C L Hsieh, R Scharting, U Francke, J R Parnes.   

Abstract

We have recently reported the isolation of cDNA clones encoding the human homolog of the mouse B cell differentiation antigen Lyb-2. Expression of Lyb-2 is restricted to B lineage cells and turned off in antibody-secreting plasma cells in both mice and humans. Functional studies with anti-mouse Lyb-2 monoclonal antibodies (mAb) suggest that this protein may be involved in signals for B cell proliferation. We now describe the generation of mAb specific for human Lyb-2. Furthermore, we demonstrate that the human Lyb-2 protein is recognized by a mAb specific for the newly clustered pan B cell surface antigen CD72, which had been defined by mAb. Mouse L(tk-) cells expressing a transfected cDNA encoding human Lyb-2 bind a mAb specific for CD72. We further show that an antiserum and a mAb specific for human Lyb-2 and an anti-CD72 mAb immunoprecipitate the identical protein from human splenic B cells and B cell lines, as well as from transfected L(tk-) cells. These data indicate that CD72 is the human equivalent of mouse Lyb-2. We have additionally localized the gene for human Lyb-2/CD72 on the short arm of chromosome 9. Mouse Lyb-2 had been previously mapped to mouse chromosome 4. Lyb-2/CD72 is now the tenth gene known to be localized on human chromosome 9 and mouse chromosome 4.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044654     DOI: 10.1002/eji.1830210615

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  2 in total

1.  Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes.

Authors:  A Katira; M Kamal; J Gordon
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

2.  CD72, a coreceptor with both positive and negative effects on B lymphocyte development and function.

Authors:  Hsin-Jung Wu; Subbarao Bondada
Journal:  J Clin Immunol       Date:  2008-12-06       Impact factor: 8.542

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.